TY - JOUR T1 - What potential risk reduction could be achieved with evolocumab treatment? A simulation based on observational data from a cohort of users in 10 European countries JO - European Heart Journal PY - 2020/11/01 AU - Ray KK AU - Bridges I AU - Bruckert E AU - Van Hout B AU - Sibartie M AU - Villa G ED - DO - DOI: 10.1093/ehjci/ehaa946.3004 PB - Oxford University Press (OUP) VL - 41 IS - Supplement_2 Y2 - 2025/05/20 ER -